Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up to 20.1 percent of their body weight on eloralintide.

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.

Preliminary research suggests that NG101, a drug from Neurogastrx, may lower the risk of nausea and vomiting in people taking semaglutide.

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives for weight loss include the injections Wegovy®, Mounjaro®, Zepbound®,

Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a person loses while taking the GLP-1 medication, a new study finds.

The medications seem to dampen the effects of drugs ranging from nicotine to alcohol—but scientists haven’t been able to fully figure out why. The study authors suggest that understanding the drugs’ mechanism in the entire body—not just the brain—could open up avenues for treating alcohol use disorder.

In recent months, a growing number of women taking the medication Ozempic, which has surged in popularity all across the world. Originally developed to treat type 2 diabetes, many women have now, rather shockingly, reported becoming pregnant despite using contraceptives.